Diago-Muñoz Diana María, Martínez-Varea Alicia, Alonso-Díaz Ricardo, Perales-Marín Alfredo, Diago-Almela Vicente José
Department of Obstetrics and Gynecology, General University Hospital, 46014 Valencia, Spain.
Department of Obstetrics and Gynecology, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain.
J Pers Med. 2025 Jan 19;15(1):37. doi: 10.3390/jpm15010037.
To assess the usefulness of first amniotic sac Interleukin-6 (IL-6) to rule out intra-amniotic inflammation (IAI), as well as maternal blood c-reactive protein (CRP), to select patients with a twin pregnancy who may benefit from an emergency cerclage. : Retrospective, descriptive study among all patients with a twin pregnancy and mid-trimester bulging membranes admitted to a tertiary Hospital from January 2012 to September 2023. According to the Hospital's Protocol, all patients received a vaginal and abdominal ultrasound, a maternal blood test, and an amniocentesis of the first sac to rule out IAI, defined by IL-6 ≥ 2.6 ng/dL. A total of 28 patients with a twin pregnancy and mid-trimester bulging membranes were included. Among them, 18 patients (64.28%) had IL-6 levels ≥ 2.6 ng/dL. Cerclage was placed in 10 patients with IL-6 < 2.6 ng/dL. Perinatal mortality in pregnancies with IL-6 ≥ 2.6 ng/dL was 77.22%. The gestational age at delivery of patients with IL-6 < 2.6 ng/dL was 34 ± 3 weeks, compared to 23 ± 4 weeks when IL-6 was ≥2.6 ng/dL ( < 0.001). The latency to delivery with IL-6 < 2.6 ng/dL was 88.1 ±31.56 days, compared to 13.11 ± 20.43 days when IL-6 was ≥2.6 ng/dL ( < 0.001). Significant differences were found in maternal blood CRP levels in both study groups (no IAI 4.32 ± 3.67 vs. IAI 13.32 ± 15.07, < 0.05). The area under the curve with an ROC curve was 0.799 (IC 95% 0.596-0.929), with a cut-off of 3.9 mg/L (S 94.4%, % E 62.5%). The gestational age at delivery with CRP < 3.9 mg/L was 33 ± 5 weeks, while in cases with CRP ≥ 3.9 mg/L, it was 24 ± 5 weeks ( < 0.001). The latency days to delivery were 86.5 ± 44.88 and 21.95 ± 30.97 days ( < 0.01), respectively. A positive correlation between the IL-6 values of both amniotic sacs was obtained, along with the Spearman coefficient correlation rank (rho = 0.835, < 0.001). Compared to those with IAI, patients with a twin pregnancy and mid-trimester bulging membranes without IAI who underwent emergency cerclage had a significantly higher interval from diagnosis to delivery, as well as a significantly lower incidence of preterm birth < 34 weeks and perinatal death. Further studies are needed to assess whether the IL-6 of the first amniotic sac and maternal blood CRP might constitute a useful parameter to select patients who may benefit from an emergency cerclage.
评估首次羊膜囊白细胞介素-6(IL-6)用于排除羊膜腔内炎症(IAI)以及母体血C反应蛋白(CRP)的有效性,以筛选可能从紧急宫颈环扎术中获益的双胎妊娠患者。:对2012年1月至2023年9月入住三级医院的所有双胎妊娠且孕中期胎膜膨出的患者进行回顾性描述性研究。根据医院方案,所有患者均接受阴道和腹部超声检查、母体血液检测以及对第一个羊膜囊进行羊膜腔穿刺以排除IAI,IAI定义为IL-6≥2.6 ng/dL。共纳入28例双胎妊娠且孕中期胎膜膨出的患者。其中,18例患者(64.28%)的IL-6水平≥2.6 ng/dL。对10例IL-6<2.6 ng/dL的患者进行了宫颈环扎术。IL-6≥2.6 ng/dL的妊娠围产期死亡率为77.22%。IL-6<2.6 ng/dL的患者分娩时的孕周为34±3周,而IL-6≥2.6 ng/dL时为23±4周(<0.001)。IL-6<2.6 ng/dL时从诊断到分娩的间隔时间为88.1±31.56天,而IL-6≥2.6 ng/dL时为13.11±20.43天(<0.001)。在两个研究组的母体血CRP水平上发现了显著差异(无IAI组为4.32±3.67,IAI组为13.32±15.07,<0.05)。ROC曲线下面积为0.799(95%置信区间为0.596 - 0.929),截断值为3.9 mg/L(敏感度94.4%,特异度62.5%)。CRP<3.9 mg/L的患者分娩时的孕周为33±5周,而CRP≥3.9 mg/L的患者为24±5周(<0.001)。从诊断到分娩的间隔天数分别为86.5±44.88天和21.95±30.97天(<0.01)。两个羊膜囊的IL-6值之间存在正相关,Spearman系数相关秩为(rho = 0.835,<0.001)。与有IAI的患者相比,双胎妊娠且孕中期胎膜膨出但无IAI且接受紧急宫颈环扎术的患者从诊断到分娩的间隔时间显著更长,早产<34周和围产期死亡的发生率显著更低。需要进一步研究来评估首次羊膜囊的IL-6和母体血CRP是否可能构成筛选可能从紧急宫颈环扎术中获益患者的有用参数。